[1]
“Survival analysis of single agent gemcitabine therapy in patients with metastatic breast cancer ”, Ann Med Res , vol. 26, no. 9, pp. 1773–1776, May 2021, Accessed: Apr. 26, 2025. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/1741